A Phase 1 trial of Ebola vaccine is showing promising results, say researchers, adding that they are one step closer to developing Ebola vaccine. But it will be months at the earliest before it can be used in the field. The news comes amid the worst ever outbreak of the hemorrhagic fever, which has killed 5,500 people so far, mostly in West Africa. Pharmaceutical companies and health agencies scramble to fast-track experimental drugs and vaccines that ...
Read More
You have just read an article categorized health
titled First Human Trials of Ebola Vaccine is Promising: NIH.
Written by:
editor -
Friday, November 28, 2014
There are currently no comments for "First Human Trials of Ebola Vaccine is Promising: NIH"
Post a Comment